Sept 20 (Reuters) - Swiss medical technology company Ypsomed YPSN.S announced on Wednesday a long-term supply deal with Novo Nordisk NOVOb.CO for autoinjectors, the latest sign of how the Danish ...
LONDON, Nov 22 (Reuters) - Swiss medical technology company Ypsomed's (YPSN.S), opens new tab contract with Novo Nordisk includes the supply of injection pens for the Danish drugmaker's ...
Lannett has entered into an agreement with Ypsomed AG, the manufacturer and supplier of the pen injector device to be used in connection with its biosimilar insulin glargine and biosimilar insulin ...
BOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today announced ...
Holly Springs, N.C. — Ypsomed AG, a Switzerland-based maker of self-injection systems for the administration of liquid medicines, plans to invest $195.4 million to establish its first North American ...
After selling off a portion of its diabetes care business last year, Ypsomed is now fully exiting the diabetes care business with a plan to trade its insulin pump development arm and remaining ...
LEHI, Utah--(BUSINESS WIRE)--Civica, Inc. (Civica, Civica Rx) today announced the selection of Ypsomed AG as the manufacturer and supplier of insulin dosing injector pens for Civica’s affordable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback